Literature DB >> 20371602

X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells.

Kate L Jones1, Michael Roche, Michael P Gantier, Nasim A Begum, Tasuku Honjo, Salvatore Caradonna, Bryan R G Williams, Johnson Mak.   

Abstract

It has been assumed that R5 and X4 HIV utilize similar strategies to support viral cDNA synthesis post viral entry. In this study, we provide evidence to show that R5 and X4 HIV have distinct requirements for host cell uracil DNA glycosylase (UNG2) during the early stage of infection. UNG2 has been previously implicated in HIV infection, but its precise role remains controversial. In this study we show that, although UNG2 is highly expressed in different cell lines, UNG2 levels are low in the natural host cells of HIV. Short interfering RNA knockdown of endogenous UNG2 in primary cells showed that UNG2 is required for R5 but not X4 HIV infection and that this requirement is bypassed when HIV enters the target cell via vesicular stomatitis virus envelope-glycoprotein-mediated endocytosis. We also show that short interfering RNA knockdown of UNG2 in virus-producing primary cells leads to defective R5 HIV virions that are unable to complete viral cDNA synthesis. Quantitative PCR analysis revealed that endogenous UNG2 levels are transiently up-regulated post HIV infection, and this increase in UNG2 mRNA is approximately 10-20 times higher in R5 versus X4 HIV-infected cells. Our data show that both virion-associated UNG2 and HIV infection-induced UNG2 expression are critical for reverse transcription during R5 but not X4 HIV infection. More importantly, we have made the novel observation that R5 and X4 HIV have distinct host cell factor requirements and differential capacities to induce gene expression during the early stages of infection. These differences may result from activation of distinct signaling cascades and/or infection of divergent T-lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371602      PMCID: PMC2881786          DOI: 10.1074/jbc.M109.090126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

Authors: 
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 2.  The herpesvirus encoded dUTPase as a potential chemotherapeutic target.

Authors:  A W Studebaker; G K Balendiran; M V Williams
Journal:  Curr Protein Pept Sci       Date:  2001-12       Impact factor: 3.272

Review 3.  Repair of abasic sites in DNA.

Authors:  Grigory L Dianov; Kate M Sleeth; Irina I Dianova; Sarah L Allinson
Journal:  Mutat Res       Date:  2003-10-29       Impact factor: 2.433

4.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

5.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

6.  Isolation of a herpes simplex virus cDNA encoding the DNA repair enzyme uracil-DNA glycosylase.

Authors:  S Caradonna; D Worrad; R Lirette
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Uracil interference, a rapid and general method for defining protein-DNA interactions involving the 5-methyl group of thymines: the GCN4-DNA complex.

Authors:  W T Pu; K Struhl
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

8.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Authors:  M Bouhamdan; S Benichou; F Rey; J M Navarro; I Agostini; B Spire; J Camonis; G Slupphaug; R Vigne; R Benarous; J Sire
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 9.  Abasic sites in DNA: repair and biological consequences in Saccharomyces cerevisiae.

Authors:  Serge Boiteux; Marie Guillet
Journal:  DNA Repair (Amst)       Date:  2004-01-05

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  17 in total

Review 1.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

2.  Kidney Disease in HIV-Infected Persons.

Authors:  Robert C Kalayjian
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

3.  Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.

Authors:  Hamayun John Sharifi; Andrea K M Furuya; Robert M Jellinger; Michael D Nekorchuk; Carlos M C de Noronha
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

Review 4.  Nature, nurture and HIV: The effect of producer cell on viral physiology.

Authors:  Sergey Iordanskiy; Steven Santos; Michael Bukrinsky
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

5.  Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.

Authors:  Carolin A Guenzel; Cécile Hérate; Erwann Le Rouzic; Priscilla Maidou-Peindara; Holly A Sadler; Marie-Christine Rouyez; Louis M Mansky; Serge Benichou
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

6.  Intracellular dynamics of HIV infection.

Authors:  Janka Petravic; Paula Ellenberg; Ming-Liang Chan; Geza Paukovics; Redmond P Smyth; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

7.  Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration.

Authors:  Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.

Authors:  Laurieann Casey Klockow; Hamayun J Sharifi; Xiaoyun Wen; Meg Flagg; Andrea K M Furuya; Michael Nekorchuk; Carlos M C de Noronha
Journal:  Virology       Date:  2013-07-09       Impact factor: 3.616

9.  Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT.

Authors:  Rafael Van den Bergh; Sébastien Morin; Hans Jürgen Sass; Stephan Grzesiek; Marc Vekemans; Eric Florence; Huyen Thanh Thi Tran; Rosina Gabriel Imiru; Leo Heyndrickx; Guido Vanham; Patrick De Baetselier; Geert Raes
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

10.  Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.

Authors:  Jason A Wojcechowskyj; Jessica Y Lee; Steven H Seeholzer; Robert W Doms
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.